Browse related articlesME aims to be self-sufficient in drug production
Wednesday, April 30 - 2008 at 08:59
The Middle East's effort towards becoming self-sufficient in pharmaceutical production came under the spotlight this week at the Pharmaceutical and Biotechnology Middle East exhibition in Dubai. The combined pharmaceutical markets of the Arabian Gulf, North Africa, Levant and Iran is estimated to be valued at over $12bn and growing at an annual rate of 10%, organizers said. 'The Middle East wants to be not only self sufficient in pharmaceutical production but to also have a larger share of export, research and contract manufacturing,' said Simon Page, Group Director of Life Sciences for organisers IIR Middle East. There are already over 450 pharmaceutical manufacturers in the region.
- ADD ARTICLE TO
-
Facebook
del.icio.us
Digg">
Also consider reading:
- » Dubai ups inspections of food transport vehicles
- » New health insurance scheme for UAE nationals
- » New hospitals to open in Saudi
- » Insurance overhaul imminent
- » UN ups malaria fight
- » Cancer patient seeks $10m from tobacco company
- » Call for more tests to screen genetic disorders
- » NewBridge locates at Dubiotech
- » Abdullah receives Red Crescent medal
- » New medtech centre in Jordan
Jeff Florian, Senior ReporterWednesday, April 30 - 2008 at 08:59 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Web Feeds